Da Silva 2012.

Trial name or title	da Silva 2012
Methods	Randomised trial. Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure
Participants	88 adult patients with Chagas heart disease complicated by heart failure Conducted at the Evandro Chagas Clinical Research Institute (IPEC), Rio de Janeiro, Brazil
Interventions	Quote "All patients from both groups will take part in medical consultations every month. After each medical consultation, a pharmacist blinded to the patient’s assignment will interview all patients, to identify compliance to treatment and any drug‐related problems (DRPs). After this, all patients will interact with the clinical pharmacist. Those randomised to the control group will receive all prescription medications, while those patients randomised to the intervention group will not only receive all prescription medications but will also undergo pharmaceutical care, to solve DRPs, confirm, and reinforce their compliance to the medical prescription. Whenever the pharmacist identifies a DRP in the intervention group, s/he will interact with the physician, to solve the DRP. All patients will take part in a pharmaceutical consultation at the end of the follow‐up, to identify DRPs, complete quality‐of‐life questionnaires, and perform six‐minute‐walk tests."
Outcomes	Quality of Life ‐ evaluated using the 36‐item short‐form (SF‐36) and the Minnesota Living with HF Questionnaire (MLHFQ)
Starting date	December 2012
Contact information	Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation, Av. Brasil 4365, Rio de Janeiro, RJ 21040‐900, Brazil
Notes	Results not yet published